Price
Financials
Standalone, Rs crore| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.37 | 1.45 | 0.60 | 1.76 | 0.99 | 1.48 | 1.48 | 1.73 | 1.17 | 2.93 | 2.05 | 2.55 |
| Expenses | 0.28 | 1.40 | 0.52 | 1.64 | 0.71 | 1.33 | 1.37 | 1.53 | 0.94 | 2.71 | 1.75 | 2.31 |
| Operating Profit | 0.09 | 0.05 | 0.08 | 0.12 | 0.28 | 0.15 | 0.11 | 0.20 | 0.23 | 0.22 | 0.30 | 0.24 |
| OPM % | 24.32% | 3.45% | 13.33% | 6.82% | 28.28% | 10.14% | 7.43% | 11.56% | 19.66% | 7.51% | 14.63% | 9.41% |
| Other Income | 0.02 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.01 | 0.02 | 0.03 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.11 | 0.06 | 0.08 | 0.12 | 0.28 | 0.15 | 0.12 | 0.20 | 0.23 | 0.23 | 0.32 | 0.27 |
| Tax % | 27.27% | 33.33% | 25.00% | 25.00% | 25.00% | 26.67% | 25.00% | 25.00% | 26.09% | 26.09% | 25.00% | 25.93% |
| Net Profit | 0.08 | 0.05 | 0.06 | 0.09 | 0.21 | 0.11 | 0.09 | 0.15 | 0.17 | 0.17 | 0.24 | 0.20 |
| EPS in Rs | 0.15 | 0.09 | 0.11 | 0.16 | 0.38 | 0.20 | 0.16 | 0.27 | 0.31 | 0.31 | 0.44 | 0.37 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.33 | 0.30 | 0.98 | 2.14 | 1.73 | 3.74 | 2.40 | 1.55 | 3.47 | 5.72 | 7.87 | 8.70 |
| Expenses | 0.25 | 0.48 | 1.36 | 2.32 | 1.66 | 3.58 | 2.03 | 1.33 | 3.20 | 5.05 | 6.90 | 7.71 |
| Operating Profit | 0.08 | -0.18 | -0.38 | -0.18 | 0.07 | 0.16 | 0.37 | 0.22 | 0.27 | 0.67 | 0.97 | 0.99 |
| OPM % | 24.24% | -60.00% | -38.78% | -8.41% | 4.05% | 4.28% | 15.42% | 14.19% | 7.78% | 11.71% | 12.33% | 11.38% |
| Other Income | 0.00 | 0.00 | 0.06 | 0.08 | -5.35 | 0.01 | 0.02 | 0.01 | 0.03 | 0.01 | 0.03 | 0.06 |
| Interest | 0.01 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.07 | -0.19 | -0.32 | -0.10 | -5.28 | 0.17 | 0.39 | 0.23 | 0.29 | 0.67 | 0.99 | 1.05 |
| Tax % | 28.57% | 0.00% | 3.12% | 0.00% | 0.38% | 5.88% | 25.64% | 26.09% | 27.59% | 25.37% | 25.25% | |
| Net Profit | 0.05 | -0.19 | -0.33 | -0.11 | -5.30 | 0.15 | 0.29 | 0.17 | 0.21 | 0.50 | 0.74 | 0.78 |
| EPS in Rs | 0.09 | -0.35 | -0.60 | -0.20 | -9.69 | 0.27 | 0.53 | 0.31 | 0.38 | 0.91 | 1.35 | 1.43 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 37% | 16% | 72% | 53% | ||
| Compounded Profit Growth | 31% | 38% | 63% | 39% | ||
| Stock Price CAGR | -5% | 63% | 39% | 82% | ||
| Return on Equity | % | 64% | 54% | 52% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 | 5.47 |
| Reserves | 0.12 | 0.17 | 0.00 | -0.33 | -0.44 | -5.73 | -5.58 | -5.29 | -5.12 | -4.91 | -4.41 | -3.67 |
| Borrowings | 0.00 | 0.09 | 0.29 | 0.25 | 0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 0.13 | 0.04 | 0.18 | 0.20 | 0.20 | 0.47 | 1.04 | 1.82 | 0.56 | 1.25 | 1.21 | 1.85 |
| Total Liabilities | 5.72 | 5.77 | 5.94 | 5.59 | 5.49 | 0.21 | 0.93 | 2.00 | 0.91 | 1.81 | 2.27 | 3.65 |
| Fixed Assets | 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 |
| CWIP | 5.35 | 5.35 | 5.35 | 5.35 | 5.35 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 0.34 | 0.39 | 0.56 | 0.22 | 0.12 | 0.19 | 0.91 | 1.99 | 0.89 | 1.79 | 2.25 | 3.63 |
| Total Assets | 5.72 | 5.77 | 5.94 | 5.59 | 5.49 | 0.21 | 0.93 | 2.00 | 0.91 | 1.81 | 2.27 | 3.65 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 0.03 | -0.03 | -0.17 | -0.07 | 0.02 | 0.24 | 0.20 | -0.11 | 0.55 | -0.41 | 0.10 | 0.17 |
| Cash from Investing Activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | -0.01 | 0.00 |
| Cash from Financing Activity | 0.00 | 0.09 | 0.20 | -0.04 | 0.01 | -0.26 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Cash Flow | 0.03 | 0.05 | 0.03 | -0.11 | 0.03 | -0.02 | 0.20 | -0.11 | 0.54 | -0.42 | 0.10 | 0.17 |
| Free Cash Flow | 0.03 | -0.03 | -0.17 | -0.07 | 0.02 | 0.24 | 0.20 | -0.11 | 0.54 | -0.41 | 0.09 | 0.17 |
| CFO/OP | 23% | 12% | 94% | 18% | -11% | 343% | 125% | -30% | 250% | -152% | 15% | 18% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 152.79 | 254.39 | 292.00 | 37.24 | 6.82 | 0.00 | 11.71 | 0.00 | 9.42 | 78.89 | 85.51 | 61.22 |
| Inventory Days | 156.43 | 138.45 | 15.21 | 0.00 | 0.00 | 0.00 | 56.78 | 243.33 | 83.93 | 55.35 | ||
| Days Payable | 104.29 | 226.55 | 72.24 | 454.22 | 754.33 | 230.32 | 239.34 | |||||
| Cash Conversion Cycle | 152.79 | 306.54 | 203.90 | -19.79 | 6.82 | 0.00 | 11.71 | 0.00 | -388.03 | -432.11 | -60.88 | -122.78 |
| Working Capital Days | 152.79 | 276.52 | -73.00 | -100.56 | -66.52 | -73.84 | -43.92 | -19.77 | -77.71 | 29.45 | 44.67 | 58.90 |
| ROCE % | 3.96% | 1.41% | -3.13% | -5.74% | -1.87% | 2.78% | 1,114.29% | 86.79% | 65.93% | 83.95% | 69.93% |
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% | 18.73% |
| Public | 81.27% | 81.27% | 81.27% | 81.28% | 81.27% | 81.27% | 81.26% | 81.26% | 81.27% | 81.28% | 81.28% | 81.27% |
| No. of Shareholders | 3,286 | 3,417 | 4,307 | 4,201 | 5,102 | 5,866 | 6,024 | 6,137 | 6,048 | 5,997 | 5,858 | 5,743 |
Fundamentals
Market Cap₹ 17.5 Cr.
Current Price₹ 32.0
Stock P/E22.4
Book Value₹ 3.29
ROCE69.9 %
ROE51.8 %
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)53%
Compounded Profit Growth (TTM)39%
Standalone figures.
Valuation
Market capRs 17 Cr
Enterprise valueRs 17 Cr
P/E (TTM)22.09x
Price to book9.57x
Price to sales1.98x
EV / EBITDA15.78x
EV / EBIT15.78x
EV / sales1.92x
Price to cash flow101.36x
Earnings yield4.53%
P/E, 3-year average21.67x
P/B, 3-year average8.85x
P/E, 5-year average21.42x
P/B, 5-year average12.60x
Profitability
Operating margin (excl. other income)12.33%
Operating margin (incl. other income)12.71%
EBITDA margin12.18%
Pre-tax margin12.07%
Net profit margin8.97%
Net margin, latest quarter7.84%
ROE51.75%
ROCE69.93%
ROA25.00%
ROE, 3-year average53.21%
ROCE, 3-year average73.27%
ROA, 3-year average21.65%
ROE, 5-year average210.47%
ROCE, 5-year average284.18%
ROA, 5-year average19.29%
ROIC (approx.)60.95%
Tax rate25.25%
Other income / net worth1.67%
Growth
Sales growth (latest year)37.59%
Profit growth (latest year)48.00%
Sales CAGR, 3 years71.88%
Sales CAGR, 5 years16.04%
Profit CAGR, 3 years63.28%
Profit CAGR, 5 years37.60%
Sales growth QoQ24.39%
Profit growth QoQ-16.67%
Sales growth YoY (latest quarter)47.40%
Profit growth YoY (latest quarter)33.33%
Per share
EPS (TTM)Rs 1.43
EPS (latest year)Rs 1.35
EPS (latest quarter)Rs 0.37
EPS, 3-year averageRs 0.88
EPS, 5-year averageRs 0.70
Book value per shareRs 3.29
Sales per shareRs 15.90
Cash flow per shareRs 0.31
Free cash flow per shareRs 0.31
Efficiency
Asset turnover2.16x
Fixed asset turnover393.50x
Inventory turnover8.08x
Inventory days45 days
Debtor days61 days
Debtors turnover5.96x
Creditor days239 days
Cash conversion cycle-123 days
Working capital days59 days
Leverage
Cash and bankRs 0 Cr
Net debtRs -0 Cr
Net debt / EBITDA-0.47x
Interest coverage106.00x
Owners' fund to total sources49.32%
Cash flow
Cash from Operating Activity (latest year)Rs 0 Cr
Net Cash Flow (latest year)Rs 0 Cr
Free cash flow (latest year)Rs 0 Cr
Cash from ops / profit, 5 years0.16x
Sales to cash flow46.29x
Statement figures
Net sales (TTM)Rs 9 Cr
Net sales (latest year)Rs 8 Cr
Sales (latest quarter)Rs 3 Cr
Operating profit excl. other income (latest year)Rs 1 Cr
Operating profit (latest quarter)Rs 0 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs 1 Cr
PBDT (TTM)Rs 1 Cr
Profit before tax (TTM)Rs 1 Cr
Tax (latest year)Rs 0 Cr
Net profit (TTM)Rs 1 Cr
Net profit (latest year)Rs 1 Cr
Net profit (latest quarter)Rs 0 Cr
Interest (TTM)Rs 0 Cr
Cost of goods sold (latest year)Rs 3 Cr
Total expenditure (latest year)Rs 7 Cr
Total income (latest year)Rs 8 Cr
Share capitalRs 5 Cr
ReservesRs -4 Cr
Shareholders' fundsRs 2 Cr
Total assetsRs 4 Cr
Net blockRs 0 Cr
ReceivablesRs 1 Cr
InventoryRs 0 Cr
Other liabilitiesRs 2 Cr
Shares outstanding (crore)0.55
Ownership
Promoter holding18.73% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
P/E 22.1 is at the 55th percentile of its own 5.4-year range
(median 21.4, low 8.7, high 72.7).
P/B 9.57 is at the 47th percentile (median 9.61).
Monthly. Market cap from split-adjusted price; profit and book value as reported by that month. A low percentile means cheap versus its own history, not cheap versus peers.
| Period | 538874 | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -1.4% | -2.8% | +1.3 pts |
| 1 month | +40.4% | -6.8% | +47.2 pts |
| 3 months | +50.0% | -7.6% | +57.6 pts |
| 3 years | +170.3% | +14.2% | +156.1 pts |
| 5 years | +1062.0% | +27.9% | +1034.1 pts |
Red flags
F-score 5 of 8| explain | Weak cash conversion Cash from operations was -10% of net profit over the last 3 years |
| explain | High accruals Profit exceeded operating cash by 16% of total assets in 2026 |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Jun 2026Sales ₹3 Cr +47.4% vs Jun 2025.
Net profit ₹0 Cr +33.3%.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| CRISIL Ltd | 32,646 | 36.9 | 32.6 % |
| RRP Semiconductor Ltd | 11,182 | -32.7 % | |
| Onemi Technology Solutions Ltd | 6,359 | 20.1 | 22.7 % |
| Asset Reconstruction Company (India) Ltd | 4,640 | 13.2 | 14.0 % |
| Colab Platforms Ltd | 2,622 | 542 | 22.4 % |
| Algoquant Fintech Ltd | 1,857 | 41.5 | 31.4 % |
| GYFTR Ltd | 1,198 | 54.9 | 6.77 % |
| Prime Securities Ltd | 1,033 | 60.6 | 8.25 % |
| Centrum Capital Ltd | 996 | 7.33 % | |
| Wealth First Portfolio Managers Ltd | 949 | 28.7 | 34.6 % |
| RNFI Services Ltd | 792 | 27.9 | 27.3 % |
| Stellant Securities (India) Ltd | 530 | 14.5 | 71.7 % |
| The Investment Trust of India Ltd | 473 | 14.5 | 8.54 % |
| Akiko Global Services Ltd | 467 | 24.2 | 37.3 % |
| Regency Fincorp Ltd | 415 | 24.0 | 10.5 % |
No bulk or block deals on record.
No corporate actions on record.
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Nexus Surgical and Medicare Ltd?
Nexus Surgical and Medicare Ltd (538874) has a market capitalisation of Rs 17.5 Cr. at the 2026-10-01 close.
What is the P/E ratio of Nexus Surgical and Medicare Ltd?
Nexus Surgical and Medicare Ltd trades at a P/E of 22.4 on trailing twelve-month profit, at the 2026-10-01 close.
What were Nexus Surgical and Medicare Ltd's latest quarterly results?
In the Jun 2026 quarter, Nexus Surgical and Medicare Ltd sales was Rs 3 Cr (+47.4% vs Jun 2025) and net profit was Rs 0 Cr.